Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial by Lopes, Renato D., MD, MHS, PhD, Alings, Marco, MD, PhD, Connolly, Stuart J., MD, Beresh, Heather, MSc, Granger, Christopher B., MD, Mazuecos, Juan Benezet, MD, Boriani, Giuseppe, MD, PhD, Nielsen, Jens C., MD, DMSc, Conen, David, MD, MPH, Hohnloser, Stefan H., MD, Mairesse, Georges H., MD, Mabo, Philippe, MD, Camm, A. John, MD, Healey, Jeffrey S., MD, MSc

Get full text